All participants in the Phase 3 clinical trial of Taiwan-based Medigen Vaccine Biologics Corp.'s COVID-19 vaccine in Paraguay have now received two shots of either the Medigen or AstraZeneca vaccine, the company said Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
1 pedestrian killed, 15 injured after rear-end bus collision in Taipei
11/17/2024 01:31 PM - Society
Taiwan headline news
11/17/2024 12:10 PM - Society
Taipei Zoo to sue man who climbed over railing to tease, feed hyenas
11/17/2024 10:59 AM - Society
One angler dies after waves knock 7 off rock in Keelung
11/16/2024 11:17 PM - Sports
Taiwan suffers 1st Premier12 loss to defending champion Japan
11/16/2024 10:46 PM